
Annual report 2021
added 12-23-2023
Burning Rock Biotech Limited Market Cap 2011-2026 | BNR
As of April 15, 2026 Burning Rock Biotech Limited has a market cap of $ 212 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Burning Rock Biotech Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 2.95 B | - | - | - | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.95 B | 2.95 B | 2.95 B |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Diagnostics research industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
221 M | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
42 B | $ 120.73 | 0.28 % | $ 36.7 B | ||
|
Aspira Women's Health
AWH
|
45.4 M | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
5.93 M | - | -13.05 % | $ 7.29 M | ||
|
Check-Cap Ltd.
CHEK
|
4.33 M | - | - | $ 9.42 M | ||
|
Chembio Diagnostics
CEMI
|
12.6 M | - | 0.22 % | $ 16.8 M | ||
|
Medpace Holdings
MEDP
|
13 B | $ 522.71 | 0.52 % | $ 15.1 B | ||
|
CareDx, Inc
CDNA
|
993 M | $ 17.77 | 0.77 % | $ 947 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
421 M | - | - | $ 562 M | ||
|
DermTech
DMTK
|
42.4 M | - | -11.32 % | $ 2.94 M | ||
|
Akumin
AKU
|
75.1 M | - | -17.87 % | $ 25.9 M | ||
|
Natera
NTRA
|
5.31 B | $ 211.83 | -1.31 % | $ 20.8 B | ||
|
Enzo Biochem
ENZ
|
57.5 K | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
5.85 M | $ 1.4 | 1.45 % | $ 1.86 M | ||
|
Koninklijke Philips N.V.
PHG
|
30.8 B | $ 29.09 | - | $ 20 B | ||
|
Exact Sciences Corporation
EXAS
|
19.5 B | - | - | $ 19.8 B | ||
|
Accelerate Diagnostics
AXDX
|
40.3 M | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
709 M | $ 24.73 | 1.46 % | $ 687 M | ||
|
Senseonics Holdings
SENS
|
351 M | $ 6.85 | 1.48 % | $ 286 M | ||
|
Global Cord Blood Corporation
CO
|
243 M | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
481 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
1.54 B | - | 0.12 % | $ 80.1 M | ||
|
Soleno Therapeutics
SLNO
|
2.08 B | $ 52.6 | -0.05 % | $ 2.67 B | ||
|
Charles River Laboratories International
CRL
|
7.69 B | $ 183.05 | 2.09 % | $ 9.07 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
7.87 B | - | - | $ 10.7 B | ||
|
Neuronetics
STIM
|
81.1 M | $ 1.44 | 0.35 % | $ 95 M | ||
|
Interpace Biosciences
IDXG
|
7.34 M | $ 2.2 | - | $ 9.73 M | ||
|
Danaher Corporation
DHR
|
150 B | $ 198.66 | 0.02 % | $ 142 B | ||
|
Heska Corporation
HSKA
|
844 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
2.99 M | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
16.4 B | $ 131.2 | 0.68 % | $ 20.9 B | ||
|
Thermo Fisher Scientific
TMO
|
196 B | $ 527.7 | 0.09 % | $ 199 B | ||
|
NeoGenomics
NEO
|
1.48 B | $ 8.62 | 3.23 % | $ 1.1 B | ||
|
Trinity Biotech plc
TRIB
|
120 M | $ 0.71 | -0.7 % | $ 61.9 M | ||
|
Fulgent Genetics
FLGT
|
467 M | $ 16.18 | 1.0 % | $ 489 M | ||
|
Twist Bioscience Corporation
TWST
|
1.56 B | $ 56.72 | -1.2 % | $ 3.39 B | ||
|
Motus GI Holdings
MOTS
|
990 K | - | -34.28 % | $ 263 K | ||
|
Guardant Health
GH
|
13.4 B | $ 85.26 | -1.32 % | $ 10.7 B | ||
|
QIAGEN N.V.
QGEN
|
8.52 B | - | - | $ 10.6 B | ||
|
Myriad Genetics
MYGN
|
409 M | $ 5.27 | 7.23 % | $ 488 M | ||
|
Anixa Biosciences
ANIX
|
104 K | $ 2.88 | - | $ 93.5 K | ||
|
Biomerica
BMRA
|
7.19 M | $ 2.11 | 0.48 % | $ 4.85 M | ||
|
ICON Public Limited Company
ICLR
|
16.6 B | $ 114.25 | 1.05 % | $ 9.42 B | ||
|
Laboratory Corporation of America Holdings
LH
|
23.9 B | $ 268.6 | -0.1 % | $ 22.3 B | ||
|
Celcuity
CELC
|
5.37 B | $ 120.17 | -0.56 % | $ 5.62 B | ||
|
Neogen Corporation
NEOG
|
1.02 B | $ 9.53 | -0.83 % | $ 2.07 B | ||
|
Lantheus Holdings
LNTH
|
5.12 B | $ 83.04 | 0.36 % | $ 5.6 B | ||
|
Quest Diagnostics Incorporated
DGX
|
23.3 B | $ 192.47 | -0.87 % | $ 21.4 B |